Joint Tea
Joint Tea, licence 80077970: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Pure trim® joint tea
- Licence holder
- Awareness Corporation Canada
- NPN or DIN-HM
- 80077970
- Status
- Inactive licence
- Licence date
- 1 June 2017
- Revision date
- 5 November 2018
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- À vérifier
Serratiopeptidase is listed in the Novel Food Catalogue as a novel food not yet authorised in the European Union: in the form covered by the entry, it should not be sold until authorised. The catalogue is informative; a declaration in France is not an authorisation.
POL-NF-00692. Novel Food Catalogue (status of products under Regulation (EU) 2015/2283), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Serratiopeptidase Source : Serratia marcescens E-15 - Cellule Entiière | 33.0 mg | Not calculated |
| Bromélaïne de tige Source : Ananas comosus var. comosus - Tige | 600000.0 FCC PU | Not calculated |
| Bromélaïne de tige Source : Ananas comosus var. comosus - Tige | 25.0 mg | Not calculated |
| Insaponifiables d'avocat/soja Source : Glycine max - Graine Potency : 30.0 % Free plant sterols | 300.0 mg | Not calculated |
| Insaponifiables d'avocat/soja Source : Persea americana - fruit Potency : 30.0 % Free plant sterols | 300.0 mg | Not calculated |
| Curcuma longa Source : Rhizome Potency : 20.0 % Curcuminoids | 200.0 mg | Not calculated |
| Serratiopeptidase Source : Serratia marcescens E-15 - Cellule Entiière | 20000.0 SU | Not calculated |
| Acide hyaluronique Source : Hyaluronate de sodium | 30.0 mg | Not calculated |
| Acide hyaluronique Source : Streptococcus equi - capsule extracellulaire bactérienne | 30.0 mg | Not calculated |
| Magnésium Source : Magnesium citrate, tribasic | 103.0 mg | Not calculated |
| Lithothamnion corallioides Source : Lithothamnion corallioides - En entier Potency : 32.0 % Calcium | 100.0 mg | Not calculated |
| Lithothamnion corallioides Source : Lithothamnion corallioides - En entier Potency : 2.2 % Magnesium | Not specified | Not calculated |
Non-medicinal ingredients
farine de riz, Huile de tournesol, Mélange de concentré de tocophérols, Spirulina platensis, entière, Saveur de fraises mélangées, Acide citrique, Lécithine, Rébaudioside A, Inuline, Mélange de fruit et légume, Dioxyde de silicium, Sucralose, Maltodextrine, Extrait de fruit de monk, Gomme arabique (acacia), Mélange de germes, Fruit de Carica papaya (Papaye)
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Mesures | minimum: 1.0 Tous les jours ; maximum: 2.0 Tous les jours |
Uses authorised in Canada
Helps to reduce joint pain associated with osteoarthritis knee. Helps in the development and maintenance of bones. Used in herbal medicine to help relieve minor pain, swelling and inflammation (anti-inflammatory).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity (e.g. allergy) has been known to occur; in which case, discontinue use. Some people may experience mild gastrointestinal disturbances such as diarrhoea, abdominal pain, heartburn, nausea and vomiting; in which case, discontinue use.
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Consult a health care practitioner if symptoms persist or worsen. If you have a gastrointestinal lesion/ ulcer, are taking an anticoagulant/blood thinner, anti-inflammatory or antibiotic, or are having surgery, consult a health care practitioner prior to use. If you have gallstones or a bile duct obstruction, consult a health care practitioner prior to use. If you have stomach ulcers or excess stomach acid, consult a health care practitioner prior to use.
Source
Official Health Canada record, licence 80077970
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2018. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.